Becker, G., Silva, S. D., Sabo, A., Antal, M. C., Kemmel, V., & Monassier, L. (2021). Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer? MDPI AG.
Cita Chicago Style (17a ed.)Becker, Guillaume, Sylvia Da Silva, Amelia-Naomi Sabo, Maria Cristina Antal, Véronique Kemmel, y Laurent Monassier. Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer? MDPI AG, 2021.
Cita MLA (8a ed.)Becker, Guillaume, et al. Blood–Brain Barrier Permeability: Is 5-Hydroxytryptamine Receptor Type 4 a Game Changer? MDPI AG, 2021.
Precaución: Estas citas no son 100% exactas.